Coreline Soft Information

Coreline Soft is a medical AI company specializing in chest CT image analysis. We develop AI-powered solutions that support the early detection and quantitative assessment of lung cancer, COPD, and coronary artery calcification (CAC), enabling faster, more consistent, and better-informed clinical decision-making. Our flagship platform, AVIEW, is deployed across more than 500 clinical sites in 19 countries and has supported over 2.5 million real-world clinical analyses. Coreline Soft’s solutions have received multiple U.S. FDA 510(k) clearances and CE marking under the EU Medical Device Regulation (MDR), supporting their adoption across the United States, Europe, and other global markets. AVIEW is backed by a growing body of clinical evidence spanning more than 500 peer-reviewed publications and scientific presentations. Founded in 2012, Coreline Soft brings together clinical expertise and AI engineering to address real challenges in medical imaging and clinical workflows. Building on our expertise in chest CT, we are working to establish a broader standard for the early detection and management of thoracic diseases.